VCAM1 and atherosclerosis: Antibodies blocking either VCAM-1 or the β1 or β2 integrins greatly reduce monocyte adhesion [15], and genetic mutation of ICAM-1 or VCAM-1 reduces atherosclerosis in mice [3], [13], [16].